Lasa Supergeneri

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE670X01014
  • NSEID: LASA
  • BSEID: 540702
INR
7.84
-0.01 (-0.13%)
BSENSE

Aug 10

BSE+NSE Vol: 1.4 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1002834,
    "name": "Lasa Supergeneri",
    "stock_name": "Lasa Supergeneri",
    "full_name": "Lasa Supergenerics Ltd",
    "name_url": "stocks-analysis/lasa-supergeneri",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "7.84",
    "chg": -0.01,
    "chgp": "-0.13%",
    "dir": -1,
    "prev_price": "7.85",
    "mcapval": "40.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540702,
    "symbol": "LASA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE670X01014",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": "1.4 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/lasa-supergeneri-1002834-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Lasa Supergenerics Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-lasa-supergenerics-ltd-4001772",
        "imagepath": "",
        "date": "2026-05-20 23:19:15",
        "description": "Lasa Supergenerics Ltd is scheduled to declare its results on 29 May 2026...."
      }
    ],
    "total": 15,
    "sid": "1002834",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/lasa-supergenerics-1002834"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for The Quarter Ended June 302026",
      "datetime": "04-Aug-2026",
      "details": "Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Friday August 14 2026 inter alia; 1. To consider approve and take on records Unaudited financial results of the Company for the quarter ended June 30 2026. 2. To discuss any other matter with the permission of the Chairperson.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "29-Jun-2026",
      "details": "Closure of trading window for the quarter ended June 30 2026",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "30-May-2026",
      "details": "Annual Secretarial Compliance Report as on March 31st 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "14 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Lasa Supergenerics Ltd has declared <strong>2%</strong> dividend, ex-date: 16 Sep 22",
          "dt": "2022-09-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Board Meeting Intimation for The Quarter Ended June 302026

04-Aug-2026 | Source : BSE

Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Friday August 14 2026 inter alia; 1. To consider approve and take on records Unaudited financial results of the Company for the quarter ended June 30 2026. 2. To discuss any other matter with the permission of the Chairperson.

Closure of Trading Window

29-Jun-2026 | Source : BSE

Closure of trading window for the quarter ended June 30 2026

Compliances-Reg.24(A)-Annual Secretarial Compliance

30-May-2026 | Source : BSE

Annual Secretarial Compliance Report as on March 31st 2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

14 Aug 2026

stock-summary
DIVIDEND

Lasa Supergenerics Ltd has declared 2% dividend, ex-date: 16 Sep 22

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available